Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06112912 · ClinicalTrials.gov registry record
Components Study of REAL Essentials
A clinical trial, sponsored by Mathematica Policy Research.
- Completed
- Registry status
- 1,301
- Enrollment target
NCT06112912: Completed study, sponsored by Mathematica Policy Research.
NCT06112912 is a clinical trial that has completed, run by Mathematica Policy Research. The registered enrollment target is 1,301 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06112912 has completed, sponsored by Mathematica Policy Research.
- COMPLETED
- Registry status
- 1,301 participants
- Enrollment target
Study Summary
The Components Study of REAL Essentials (REA) is a descriptive implementation and outcome study. This study aims to identify the components that matter most for promoting positive health behaviors and outcomes among adolescents. The study will examine a variety of components to determine which are most influential in predicting participant outcomes. In addition, the study will measure youth engagement in programming from various perspectives and examine the role of engagement as an intermediary factor to achieving youth outcomes.
Primary Outcome
There are two scales that are used to represent the conflict management skills construct: conflict resolution (alpha = .82), calculated as an average across six Likert items (scores ranging from 1 = very difficult to 5 = very easy) that ask how easy the prompt is (e.g., talk to my classmates about how I feel when I am upset with them). Conflict management (alpha = .84), calculated as an average across five Likert items (scores ranging from 1 = very difficult to 5 = very easy) that ask how easy o
Interventions
- OTHER REAL Essentials Advance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,301 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2023-06-30 |
What the finished NCT06112912 record still lists
NCT06112912 is an observational study that tracks outcomes without assigning an intervention. Its 1,301 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which REAL Essentials Advance is the first listed.
NCT06112912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06112912 about?
NCT06112912 is a clinical study titled "Components Study of REAL Essentials". The Components Study of REAL Essentials (REA) is a descriptive implementation and outcome study. This study aims to identify the components that matter most for promoting positive health behaviors and outcomes among adolescents. The study will examine a variety of components to determine which are m...
What is the current status of trial NCT06112912?
This trial is currently completed. The enrollment target is 1,301 participants. The study started on 2022-01-01. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT06112912?
The interventions under investigation include: REAL Essentials Advance (OTHER).
Who is sponsoring clinical trial NCT06112912?
This trial is sponsored by Mathematica Policy Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI